Stay updated on Sage-217 Adjunctive Therapy in Depression Clinical Trial
Sign up to get notified when there's something new on the Sage-217 Adjunctive Therapy in Depression Clinical Trial page.

Latest updates to the Sage-217 Adjunctive Therapy in Depression Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded a new Locations section listing study sites across Alabama, Arizona, California, Colorado, Connecticut, Florida, Georgia, Illinois, Maryland, Massachusetts, Michigan, Missouri, Nebraska, New Jersey, New Mexico, New York, Ohio, Oklahoma, Pennsylvania, Texas, and Washington, with Revision: v3.3.3. The old per-state location sections were removed in this update.SummaryDifference1%

- Check28 days agoNo Change Detected
- Check49 days agoChange DetectedThe Publications section wording was updated to clarify that entries are auto-filled from PubMed, and the revision label updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check56 days agoChange DetectedRemoved a government funding/operating status banner from the page; study details, locations, and trial information remain unchanged.SummaryDifference0.2%

- Check70 days agoChange DetectedNo significant additions or deletions to core study details were detected between the two screenshots; observed differences appear to be cosmetic formatting updates and updated dates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check99 days agoChange DetectedAdded a government-funding/status notice and upgraded version to v3.2.0; removed the old v3.1.0 tag.SummaryDifference2%

- Check106 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.0%

Stay in the know with updates to Sage-217 Adjunctive Therapy in Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sage-217 Adjunctive Therapy in Depression Clinical Trial page.